Evidence map›Paper›PMID 35641813›Full record

ArticleJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2022

Tissue Content and Pattern of Expression of Claudin-3 and Occludin in Normal and Neoplastic Tissues in Patients with Colorectal Cancer.

Roberta Laís Mendonça de Mattos, Danilo Toshio Kanno, Fábio Guilherme Campos, Geovanna Pacciulli Pereira, Mateus Magami Yoshitani, Andress de Godoy Delben, José Aires Pereira, Carlos Augusto Real Martinez

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Claudins in Cancer: A Current and Future Therapeutic Target.International journal of molecular sciences · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Roberta Laís Mendonça de MattosPost-Graduate Program in Healt Sciences, São Francisco University Medical School, Bragança Paulista, São Paulo, Brazil.
Danilo Toshio KannoPost-Graduate Program in Healt Sciences, São Francisco University Medical School, Bragança Paulista, São Paulo, Brazil.
Fábio Guilherme CamposDepartment of Gastroenterology, Faculty of Medicine, Universidade de São Paulo, São Paulo, Brazil.
Geovanna Pacciulli PereiraFaculty of Medicine, São Francisco University Medical School, Bragança Paulista, São Paulo, Brazil.
Mateus Magami YoshitaniFaculty of Medicine, São Francisco University Medical School, Bragança Paulista, São Paulo, Brazil.
Andress de Godoy DelbenPost-Graduate Program in Sciences of Surgery, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil. andress2003@gmail.com.ORCID 0000-0003-0693-7809
José Aires PereiraDepartment of Pathology, São Francisco University Medical School, Bragança Paulista, São Paulo, Brazil.
Carlos Augusto Real MartinezPost-Graduate Program in Healt Sciences, São Francisco University Medical School, Bragança Paulista, São Paulo, Brazil.
Universidade São Francisco · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetastasis is the worst prognostic variable of patients with colorectal cancer (CRC). For the development of metastases, it is necessary that cancer cells detach from the primary tumor, migrate into the angiolymphatic system, and invade the tissue where they will develop. The breakdown of the tight junctions (TJs) plays an important role in colorectal metastatic tumors. Claudin-3 and occludin are the main component proteins of TJs.

aimTo analyze the expression and tissue content of claudin-3 and occludin in normal and neoplastic tissues of patients with metastatic CRC.

methodsFifty-seven consecutive patients with stage III and IV CRC were included. Fragments of neoplastic tissue were collected from the tumor margins, and samples of the normal tissue were collected from the same patient in a standardized distance of 10 cm from the cranial margin of the tumor. Immunohistochemistry technique was used to identify the tissue staining of claudin-3 and occludin. To measure the content of both proteins in cellular membranes of normal and cancer cells, a validated immunoscore was used.

resultsClaudin-3 and occludin in normal tissues are in the apical and lateral membranes of cells, while in the neoplastic, in cytoplasm. The mean of the tissue content of claudin-3 in the normal tissue was 2.57 ± 0.16, while in the neoplastic tissue was 1.03 ± 0.13. The contents of occludin were 2.77 ± 0.1 in normal tissue, while in the neoplastic were 1.08 ± 0.14.

conclusionThere is a reduction in the content of the claudin-3 and occludin in the cell membranes of the neoplastic tissue in patients with CRC.

Indexed as

Colorectal NeoplasmsTight JunctionsClaudin-1Claudin-3HumansOccludinClaudin-1Claudin-3OccludinClaudin-3Colorectal NeoplasmsNeoplasm MetastasisOccludinTight Junctions

Identifiers

PMID35641813
OpenAlexW4281987382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.